CURIS INC
S-1, EX-27.1, 2000-11-29
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CURIS INC, S-1, EX-23.4, 2000-11-29
Next: CURIS INC, S-1, EX-27.3, 2000-11-29



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CURIS, INC.
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>                     <C>                     <C>
<PERIOD-TYPE>                   12-MOS                   12-MOS                   12-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-1998             DEC-31-1997             DEC-31-1999
<PERIOD-START>                             JAN-01-1999             JAN-01-1998             JAN-01-1997             JAN-01-1999
<PERIOD-END>                               DEC-31-1999             DEC-31-1998             DEC-31-1997             SEP-30-1999
<CASH>                                       2,751,069              17,738,044                       0                       0
<SECURITIES>                                18,619,516              40,197,407                       0                       0
<RECEIVABLES>                                   60,296                 669,232                       0                       0
<ALLOWANCES>                                         0                       0                       0                       0
<INVENTORY>                                          0                       0                       0                       0
<CURRENT-ASSETS>                            21,577,645              58,905,584                       0                       0
<PP&E>                                       1,846,137               1,225,200                       0                       0
<DEPRECIATION>                               (519,766)               (201,094)                       0                       0
<TOTAL-ASSETS>                              28,892,291              66,164,057                       0                       0
<CURRENT-LIABILITIES>                        4,461,317               9,292,483                       0                       0
<BONDS>                                      1,009,388                 713,459                       0                       0
                                0              23,052,787                       0                       0
                                          0                       0                       0                       0
<COMMON>                                       190,995                 103,372                       0                       0
<OTHER-SE>                                  23,311,591              33,001,956                       0                       0
<TOTAL-LIABILITY-AND-EQUITY>                28,892,291              66,164,057                       0                       0
<SALES>                                              0                       0                       0                       0
<TOTAL-REVENUES>                             3,211,860              10,429,071              13,086,401               2,405,760
<CGS>                                                0                       0                       0                       0
<TOTAL-COSTS>                               17,086,355              33,692,768              31,868,617              12,540,234
<OTHER-EXPENSES>                                     0                       0                       0                       0
<LOSS-PROVISION>                                     0                       0                       0                       0
<INTEREST-EXPENSE>                             161,385                 327,304                 215,815                 114,780
<INCOME-PRETAX>                                      0                       0                       0                       0
<INCOME-TAX>                                         0                       0                       0                       0
<INCOME-CONTINUING>                       (12,109,790)            (21,395,138)            (16,651,673)             (8,631,677)
<DISCONTINUED>                                       0                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0                       0
<CHANGES>                                            0                       0                       0                       0
<NET-INCOME>                              (14,505,349)            (22,381,725)            (16,651,673)            (11,027,236)
<EPS-BASIC>                                     (1.36)                  (2.22)                  (1.68)                  (1.04)
<EPS-DILUTED>                                   (1.36)                  (2.22)                  (1.68)                  (1.04)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission